OxThera (private company)

See something wrong or missing? Let us know
Offices:Stockholm
Industry:BiotechPharma
Business model:B2B

OxThera is a biopharmaceutical company with products in late stage clinical development focusing on Primary and Secondary Hyperoxaluria.

OxThera’s intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria, and enzymes. Oxabact® holds Orphan Drug designations in Europe and in the US for the treatment of primary hyperoxaluria.

Investors: we tracked 9 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 83.05M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to OxThera

Name Criteria
Denmark STipe Therapeutics
63%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • At least one vc investor: Sunstone Life Science Ventures
  • Total raised in a similar range: 10M+ USD
Sweden Asarina Pharma
60%
  • Similar verticals: Pharma
  • Similar business models: B2B
  • At least one vc investor: Kurma Life Science Partners
  • At least one other investor: Idinvest Partners
  • Total raised in a similar range: 10M+ USD
Denmark IO Biotech
60%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Sunstone Life Science Ventures, Kurma Life Science Partners
  • At least one other investor: Idinvest Partners
  • Total raised in a similar range: 10M+ USD
Sweden Athera
53%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • At least one vc investor: Industrifonden
Sweden Aprea Therapeutics
50%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: HealthCap
  • Total raised in a similar range: 10M+ USD
Sweden BoneSupport
50%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Industrifonden, HealthCap
  • Total raised in a similar range: 10M+ USD
France Corlieve Therapeutics
50%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Kurma Life Science Partners
  • At least one other investor: Idinvest Partners
Sweden EnginZyme
50%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Industrifonden
  • Total raised in a similar range: 10M+ USD
Finland Forendo Pharma
50%
  • Similar verticals: Pharma
  • Similar business models: B2B
  • At least one vc investor: Sunstone Life Science Ventures
  • Total raised in a similar range: 10M+ USD
Denmark Galecto Biotech
50%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Sunstone Life Science Ventures
  • Total raised in a similar range: 10M+ USD
Top